|
|
Volumn 115, Issue 20, 2009, Pages 4646-
|
|
Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZENESULFONIC ACID DERIVATIVE;
PYRIDINE DERIVATIVE;
SORAFENIB;
ADJUVANT CHEMOTHERAPY;
CLINICAL PROTOCOL;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TUMOR;
NOTE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TUMOR RECURRENCE;
BENZENESULFONATES;
CARCINOMA, HEPATOCELLULAR;
CHEMOTHERAPY, ADJUVANT;
CLINICAL PROTOCOLS;
HUMANS;
LIVER NEOPLASMS;
NEOPLASM RECURRENCE, LOCAL;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 77951296192
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.24673 Document Type: Note |
|
Times cited : (57)
|
|
References (0)
|
